• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience.

作者信息

Shah S S, Deshpande A K, Kaundinya D V

机构信息

Dept. of Microbiology, Grant Medical College, Bombay.

出版信息

J Assoc Physicians India. 1995 Jun;43(6):398-9.

PMID:8906944
Abstract

Cefoperazone sodium is a broad spectrum third generation Cephalosporin recently introduced in India. This was used as a monotherapy to treat severe infections in hospitalized patients. These infections were due to various gram positive and gram negative organisms. Of the 22 evaluable patients, 21 (95%) were clinically cured and 1 (5%) improved. 18 pathogens were isolated from 17 patients. Microbiologic eradication was 100%. Symptomatic improvement occurred within 48-72 hours of onset of therapy with complete relief by 4-5 days. Dual mode of excretion makes this drug safe in presence of renal insufficiency. Anti-microbial activity against a wide spectrum of organisms and twice daily dosage schedule qualify Cefoperazone as a single antibiotic of choice in severe infections in critically ill patients.

摘要

相似文献

1
Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience.
J Assoc Physicians India. 1995 Jun;43(6):398-9.
2
Cephalosporin therapeutics for intensive care infections.用于重症监护感染的头孢菌素疗法。
New Horiz. 1993 May;1(2):181-6.
3
Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.抗生素封管疗法治疗与端口相关的肠球菌、革兰氏阴性菌或革兰氏阳性杆菌血流感染的有效性。
Diagn Microbiol Infect Dis. 2009 Feb;63(2):208-12. doi: 10.1016/j.diagmicrobio.2008.10.004. Epub 2008 Nov 21.
4
Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.耐多药革兰氏阴性菌血症和尿路感染患者肠外使用多黏菌素B:一项回顾性病例系列研究
Ann Pharmacother. 2008 Sep;42(9):1177-87. doi: 10.1345/aph.1K346. Epub 2008 Jul 29.
5
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.头孢吡肟替代给药策略对阴沟肠杆菌、弗氏柠檬酸杆菌和铜绿假单胞菌所致肺部及血流感染的影响:一项单中心、开放标签、前瞻性观察性研究。
Clin Ther. 2009 Feb;31(2):299-310. doi: 10.1016/j.clinthera.2009.02.015.
6
Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.静脉注射多黏菌素B与美罗培南治疗成人复杂性腹腔内感染的疗效和耐受性:一项III期、前瞻性、多中心、随机、双盲、非劣效性研究。
Clin Ther. 2008 May;30(5):868-83. doi: 10.1016/j.clinthera.2008.04.019.
7
Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.伊洛林地区的新生儿败血症:细菌病原体及抗生素敏感性模式
Afr J Med Med Sci. 2002 Jun;31(2):127-30.
8
In vitro activity of cefoperazone-sulbactam: Singapore experience.头孢哌酮-舒巴坦的体外活性:新加坡的经验
Southeast Asian J Trop Med Public Health. 1996 Dec;27(4):734-7.
9
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.革兰氏阴性菌在非中性粒细胞减少的血液系统恶性肿瘤患者的希克曼导管相关感染中占主导地位。
J Infect. 2008 Apr;56(4):227-33. doi: 10.1016/j.jinf.2008.01.046. Epub 2008 Mar 17.
10
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.利奈唑胺与万古霉素治疗儿童耐革兰氏阳性菌感染的比较
Pediatr Infect Dis J. 2003 Aug;22(8):677-86. doi: 10.1097/01.inf.0000078160.29072.42.